Navigation Links
Grand FDA nod and approval for drug for heart transplant patients

In a relief FDA, the U.S. health regulators, gave their nod to the first new drug in nearly a decade to prevent organ rejection in heart transplant patients.//

The drug, Astellas Pharma Inc.'s Prograf, is already cleared to prevent rejection of liver and kidney transplants.

Dr. Steven Galson, head of the FDA's Center for Drug Evaluation and Research said, "The doctors who perform approximately 2,200 heart transplants in the U.S. each year will now have a new option for enhancing successful outcomes. Prograf works by suppressing the body's immune system, which can attack new organs it senses as foreign objects.”

In one study of U.S. patients, 93.5 percent of patients and their new hearts survived one year after transplant. That rate was similar to what was seen in patients given an older drug, cyclosporine.

Prograf's main chemical ingredient, tacrolimus, is also used in the Japanese company's eczema cream Protopic. so now the drug can have a wider application area and used effectively.


'"/>




Page: 1

Related medicine news :

1. Taking Care Of Grandkids Can Give Women more than a Headache
2. Grandmother’s diet in pregnancy can affect grandchildren’s blood sugr
3. British Grandmother has timely bypass surgery in India
4. Grandma Recovers Eyesight Miraculously
5. Analysis Shows Lamictal As An Effective Additional Therapy For Treatment of Grand Mal Seizures
6. Ranbaxy gets US FDA approval for Lisinopril
7. Aurobindo gets U.S. FDA approval for Cephalexin
8. Cadila gets US FDA approval for Promethazine tablets
9. Anti-obesity drugs for FDA approval
10. OTC sale for Xenical; Diet Drug; gets FDA approval
11. Starvation in pregnant women can cause heart disease to their children
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
Breaking Medicine Technology: